Table 4.
ANOVA results across Small Intestinal Neuroendocrine Tumor subtypes and corresponding metastases.
WDNET-WDNET MET | WDNEC-WDNEC MET | PDNEC-PDNEC MET | ||||
---|---|---|---|---|---|---|
Gene | p | FC | p | FC | p | FC |
Kiss1 | 5.7×10−7 | 52.8 | 1.2×10−7 | 81.2 | 0.004 | 41.6 |
MAGE-D2 | 5.2×10−3 | 5.6 | NS | −1.04 | 0.03 | 10.4 |
CgA | 0.02 | 9.08 | 0.01 | 12.4 | 0.08 | 21.1 |
Ki-67 | NS | 2.7 | 0.02 | 3.7 | NS | 1.5 |
MTA1 | 0.02 | 2.8 | NS | 1.1 | NS | 4.4 |
Survivin | NS | 4.02 | 0.05 | 4.4 | NS | 6.1 |
FZD7 | NS | 1.7 | 1.8×10−3 | 27.2 | NS | 1.2 |
NAP1L1 | NS | 1.1 | 0.01 | 12.05 | NS | −1.9 |
NRP2 | NS | 1.2 | NS | −1.6 | NS | −1.4 |
WDNET = Well Differentiated Neuroendocrine Tumors, WDNEC = Well Differentiated
Neuroendocrine Carcinomas, PDNET = Poorly Differentiated Neuroendocrine Tumors, PDNEC = Poorly Differentiated Neuroendocrine Carcinomas, MET = Metastasis
FC = Fold Change, NS = Non-significant (p≥0.05)